about
Fluorescence microscopy visualization of halomucin, a secreted 927 kDa protein surrounding Haloquadratum walsbyi cellsOvercoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectorsBacteriophage adhering to mucus provide a non-host-derived immunity.Mucins suppress virulence traits of Candida albicansCervical mucus properties stratify risk for preterm birthPredicting first traversal times for virions and nanoparticles in mucus with slowed diffusionInfluenza A Virus-Induced Expression of a GalNAc Transferase, GALNT3, via MicroRNAs Is Required for Enhanced Viral Replication.Enhanced membrane-tethered mucin 3 (MUC3) expression by a tetrameric branched peptide with a conserved TFLK motif inhibits bacteria adherence.Mucin biopolymers prevent bacterial aggregation by retaining cells in the free-swimming state.Theaflavin-3,3'-digallate and lactic acid combinations reduce herpes simplex virus infectivity.Glycomaterials for probing host-pathogen interactions and the immune response.Synthetic Mucus Nanobarriers for Identification of Glycan-Dependent Primary Influenza A Infection Inhibitors.Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.Broad-spectrum antiviral agents.A Selective Mucin/Methylcellulose Hybrid Gel with Tailored Mechanical Properties.Bifunctional thiosialosides inhibit influenza virus.Transcriptome analysis of Haloquadratum walsbyi: vanity is but the surface.Core 2 Mucin-Type O-Glycan Is Related to EPEC and EHEC O157:H7 Adherence to Human Colon Carcinoma HT-29 Epithelial Cells.Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?Macromolecular Coating Enables Tunable Selectivity in a Porous PDMS Matrix.Methods for Assessing Mucoadhesion: The Experience of an Integrative ApproachOral Mucosa: Physiological and Physicochemical AspectsMucins trigger dispersal of biofilms
P2860
Q30633144-7DCD6F84-4A2B-414F-B0F2-BB0CA20EDC8AQ30650955-48650EF6-408D-4742-93EB-78817C64A8C8Q34345695-ED4C87DF-EBA9-4BF3-BAE9-553386031E8EQ34530489-C54FEB13-7D25-40F1-86F1-0CDA37DDFBC3Q34924455-44E35CE0-5649-4982-9D22-D27D7699BA4BQ36066951-7C953853-9082-4FD0-A9E9-E3818F7E1C15Q36524003-C12DF279-77F4-454D-88B9-416540CFB1B2Q36635893-6834EF72-4517-4DB1-9234-21393289D139Q36990072-C071E163-FD4B-4FC9-936E-003E4755C164Q37036440-BB48A66A-0E63-4CB3-AF2C-D8224155CD98Q37107154-FFBA80A6-29E0-4A65-9B6F-FCF801442E89Q37374096-5B02D484-E362-4412-9438-698830555643Q37713074-C7163BD8-FDE8-4741-B692-096FA012AC93Q38519881-AFF37E5D-3AC7-4AEE-A239-312CD6399BE3Q38805292-B3C6A213-C4D6-42DE-B55E-60C0EBE23E9DQ39657656-EEEC57A1-D592-4DC3-8482-C102B64E8D68Q40968621-8745B01F-A8E1-4CFD-94F5-88BF1DD03289Q41379177-1A59001C-E7D5-4FB9-9358-7E93E6D3AEB1Q41922735-1A9A85F4-5B24-4810-A624-D72B8FA2B8DAQ47225617-AA3BC700-AC29-49A4-9FCF-75231C639946Q56031399-D27AF055-9E65-4F2E-B585-43B281CDE13FQ56031400-A61B745C-DC28-4DEF-91F1-0ACE02672A16Q57478903-63075368-A4AF-4C55-A1B3-F130F356D218
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mucin biopolymers as broad-spectrum antiviral agents.
@ast
Mucin biopolymers as broad-spectrum antiviral agents.
@en
type
label
Mucin biopolymers as broad-spectrum antiviral agents.
@ast
Mucin biopolymers as broad-spectrum antiviral agents.
@en
prefLabel
Mucin biopolymers as broad-spectrum antiviral agents.
@ast
Mucin biopolymers as broad-spectrum antiviral agents.
@en
P2860
P50
P356
P1433
P1476
Mucin biopolymers as broad-spectrum antiviral agents.
@en
P2093
Corinna Lieleg
Katharina Ribbeck
P2860
P304
P356
10.1021/BM3001292
P577
2012-05-21T00:00:00Z